Japan-based Cyfuse Biomedical raises 1.4 billion yen ($12m) to support the development of 3D printing technology which can produce human tissue.

Vectorious, which is developing an implant-based cardiac monitoring system, has raised $5m and will look to begin the first trials for the device soon.

Fosun Pharma-backed Check-Cap has received $12m in an initial public offering and an additional $12m in a private placement.

Illumina Accelerator Boost Capital will invest up to $5m a time in graduates from biotech analysis company Illumina's accelerator programme.

Brickell, an AmorePacific-backed developer of therapies for skin diseases, has secured $10m in a round that took its overall funding to more than $23m.

The Pfizer-backed cancer treatment developer, which initially floated in France in 2007, received $35m from Pfizer last year in return for a 10% stake.